TransCure will be attending TUMOUR MODELS LONDON 2019
Our CEO, Patrick NEF and our Dir. Business Development, Olivier Baverey will be in London during the Tumour Models London, December 3rd to 5th. Meet them there to talk about fully humanized immune system mouse models for immunity-targeted preclinical assessment.
Click here to pre-arrange a face-to-face:
Who are we?
TransCure bioService is a pre-clinical CRO dedicated to the evaluation of treatments for HIV,immuno-oncology, and inflammations diseases. Our team elaborates unique Research & Development (R&D) and fee-for-service platforms, called the Full Human Immune System Mouse Models (hu-mouse models). Therefore, customers access these full services (protocol design, data collection and analysis) in our BSL-2 and BSL-3 animal and laboratory facilities on a very attractive fee-for-service basis.